Veterinary Vaccines Market to Grow at a Robust Pace During 2021-2026

The Protein Engineering research report published by Stratview Research, is an in-depth analysis of the latest developments, market size, future technologies, market drivers, upcoming challenges, with key company profiles. The research study provides market overview, opportunities in the market, sales and revenue by region and much more business intel.

This research analyses niche markets, potential threats, and competitive strategy in various segments based on the Protein Engineering Market competitive landscape and development model in various parts of the world. This research throws light on the business strategies of the key players that might help in the growth of other companies during the pandemic era.

Impact of COVID-19 on Protein Engineering Market

As the world grapples with one of its greatest health pandemic, the economic and social disruption has affected millions of enterprises. The revenues have gone down in the year 2020 and may resume an uptrend gradually from 2021. Companies optimizing their operation and strategy will sustain and beat the competition. Stratview Research throws light on in-depth insights related to rapid alterations in the key players in each industry, growth and decline due to COVID-19, etc. The researchers at Stratview Research are regularly connecting with the clients and other key players of almost all the industries, regarding the impact of COVID-19 on their businesses.

Key Players involve in this research are:

• Bio-Rad Laboratories, Inc., Thermo Fisher Scientific, Inc.,
• Bruker Corporation, Agilent Technologies, Inc.,
• Waters Corporation, Danaher Corporation, Codexis, Inc.,
• New England Biolabs, Inc., PerkinElmer, Innovagen AB,
• GE Healthcare, CUSABIO TECHNOLOGY LLC,
• Promega Corporation, Merck KGaA, GenScript Biotech Corporation,
• Takara Bio, Inc., Enantis S.R.O., InvivoGen, Pace Analytical,
• Aspira Chemical, Zymeworks, Inc., Abzena, Ltd.,
• PhyNexus, Inc., ProteoGenix, Creative Biolabs.

Growth drivers and Market Value:

This report, from Stratview Research Protein Engineering Market value and growth drivers over the trend period of 2020-25. According to the report -

Protein Engineering market is likely to witness a CAGR of 12.6% during the forecast period. Increasing investments in synthetic biology and mounting focus on protein-based drug development by biotechnology and pharmaceutical companies are the major factors that are driving the protein engineering market.

Segment Analysis:

By Protein Type

Based on the protein type, the market is segmented as monoclonal antibodies, erythropoietin, interferons, vaccines, colony-stimulating factors, growth hormones, coagulation factors, and others. The monoclonal antibodies segment dominated the market in 2019, and is expected to maintain its position during the forecast period. Increasing demand for monoclonal antibodies for the treatment of cancer, neurological diseases, and infectious diseases is the major factor behind its dominance.

Regional Trends

In terms of regions, North America is estimated to be the largest market during the forecast period. Presence of well-established CROs, increasing investment towards R&D, and the availability of the latest techniques and instruments for drug discovery research are the major factors behind the dominance of the North American market.

Competitive Analysis: Understanding your rivalry is critical to your success. This section includes an analysis of your key competitors, their products/services, their differentiators, and market shares, etc.

Target Market and Audience: Identifying and prioritizing specific target markets is another key part of any industry, where research is crucial. Stratview Research’s report will help you find more about the demographics and buying behaviours of your potential customers.

Key Considerations for Market Forecast:

• Impact of lockdown, supply chain disruptions.
• Pre and post-COVID-19 market estimates
• Geographical Breakdown: Regional level analysis of the market, currently covering North America, Europe, China & Japan

Impact of COVID-19 on the Global Market

The Protein Engineering report compiled by Stratview Research offers in-depth study of market opportunities and market impact that are stirred due to the COVID-19 pandemic. The detailed research report focuses upon the direct and indirect impact of COVID-19 with new product launches, M&As, supply chain overview, government regulations, strategies adopted by related market, etc.

Sneak peek into the Report:

The report provides critical insights into the market dynamics and will enable strategic decision-making for the existing market players as well as those willing to enter the market. The following are the key features of the report:

• Market structure: Overview, industry life cycle analysis, supply chain analysis
• Market forecast analysis
• Competitive landscape and dynamics: Market share, product launches, etc.
• Attractive market segments and associated growth opportunities
• Emerging trends & Key success factors

Connect with us -

Stratview Research

E-mail: sales@stratviewresearch.com

Direct: +1-313-307-4176

Customization of the Report:

This report can be customized to meet the client’s requirements. In order to provide more accurate market forecast, all the reports are updated before delivery.

You can mail our sales team at (sales@stratviewresearch.com) and get in touch with us on +1-313-307-4176 to share your research requirements.

About Us: Stratview Research is a trusted global market intelligence and strategic consulting firm providing inclusive range of services to multiple clients across a wide array of industries. Our team of veterans and analysts have extensive experience in executing custom research projects for mid-sized to fortune companies, in the areas of Market Assessment, Opportunity Screening, Competitive Intelligence, Due Diligence, Target Screening, Market Entry Strategy, and more.

Mar 10,2021/IndustryNewsGlobal/ The unexpected shifts in the global markets because of the sudden outbreak of the COVID-19 virus have brought many major and minor tremors to industries of all sizes including the Protein Engineering Market.

It was estimated prior to this unanticipated outbreak that the Protein Engineering Market was expected to grow at a CAGR of 12.6% during the forecast period. However, the gradual slowing down of industries will undoubtedly impose limits on the previously estimated growth rate.

Protein engineering is the process of altering a protein sequence to attain a desired result such as increased stability to the temperature, organic solvents, and/or extremes of pH or a change in the substrate capacity. Protein engineering can be categorized by protein type into monoclonal antibodies, erythropoietin, interferons, vaccines, colony-stimulating factors, growth hormones, coagulation factors, and others. On the basis of products & services the market can be categorized into instruments, consumables, and software & services. On the basis of technology type, the market can be categorized into rational protein design and irrational protein design. Major end-user in the market are biopharmaceutical companies, contract research organizations, and academic research institutes.

This report studies the market covering a period of 12 years of trend and forecast. The report provides detailed insights into the market dynamics to enable informed business decision making and growth strategy formulation based on the opportunities present in the market.

Based on the products & services type, the market is segmented as instruments, consumables, and software & services. The instrument segment held the largest share of the market in 2019, and is expected to remain dominant during the forecast period. Technological advancements and the high price of mass spectroscopy and crystallography instruments are the major factors leading to dominance of the instrument segment.

Based on the protein type, the market is segmented as monoclonal antibodies, erythropoietin, interferons, vaccines, colony-stimulating factors, growth hormones, coagulation factors, and others. The monoclonal antibodies segment dominated the market in 2019, and is expected to maintain its position during the forecast period. Increasing demand for monoclonal antibodies for the treatment of cancer, neurological diseases, and infectious diseases is the major factor behind its dominance.

In terms of regions, North America is estimated to be the largest market during the forecast period. Presence of well-established CROs, increasing investment towards R&D, and the availability of the latest techniques and instruments for drug discovery research are the major factors behind the dominance of the North American market.

Asia-Pacific is expected to be the fastest-growing market during the forecast period. Advancements in genomics and proteomics research and government initiatives and funding for protein-based drug research in key countries are the major factors behind the extra-ordinary growth of the region’s market.